Tranexamic acid (TXA) is a widely used and generally safe medication for managing bleeding. However, like all pharmaceuticals, it is associated with potential side effects and requires careful consideration of its safety profile, especially regarding dosage and patient-specific factors.

One of the more discussed potential side effects of TXA is the risk of seizures. This risk appears to be dose-dependent, with higher doses, particularly those used in cardiac surgery, being more strongly associated with seizure occurrence. The mechanism is thought to involve TXA's interaction with inhibitory neurotransmitter receptors in the brain. Therefore, in procedures where higher doses are employed, careful patient monitoring is essential.

Thrombotic events, such as deep vein thrombosis (DVT) or pulmonary embolism (PE), are another area of concern, though large-scale studies in many contexts, including trauma and obstetrics, have generally not shown an increased risk. However, some trials, particularly those involving gastrointestinal bleeding or specific trauma patient subgroups, have reported an elevated rate of thrombotic complications. Patients with a history of or predisposition to thrombosis should be carefully evaluated before TXA administration.

Kidney function is also a consideration. Since TXA is primarily excreted by the kidneys, patients with renal impairment may require dose adjustments to prevent accumulation and potential toxicity. Likewise, in specific procedures like nephrolithotomy in patients with a solitary kidney, TXA use has been linked to clot obstruction and anuria, necessitating caution.

While common side effects like gastrointestinal upset can occur, they are typically mild. The potential for more serious adverse events underscores the importance of administering TXA under medical supervision. Healthcare professionals must weigh the benefits against the risks, considering the patient's underlying condition, dosage, and potential contraindications. Understanding these safety aspects ensures the appropriate and effective use of Tranexamic acid in clinical practice.